Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
4
×
ipo
life sciences
national blog main
startups
4
×
cancer
deals
fda
national top stories
new york blog main
san diego blog main
san diego top stories
san francisco blog main
venture capital
biogen
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
covid-19
deerfield management
detroit blog main
detroit top stories
drug development
europe blog main
europe top stories
gilead sciences
indiana blog main
indiana top stories
laura shawver
melinta therapeutics
national
new york top stories
novartis
oric pharmaceuticals
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
What
ipo
4
×
bio
company
covid
developing
medicines
new
plans
public
roundup
acquisitions
activity
advance
announced
approvals
biogen
biology
biotech
ceo
clamped
collabs
cytokine
daniel
deal
debut
delays
drugs
economic
enhanced
fast
fda
files
gilead
gilead’s
help
including
initial
introduce
isn’t
late
Language
unset
Current search:
ipo
×
startups
×
" boston blog main "
×
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs